Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Benjamin D. Clarke"'
Autor:
Mark D. Russell, Deepak Nagra, Benjamin D. Clarke, Sathiyaa Balachandran, April Buazon, Amy Boalch, Katie Bechman, Maryam A. Adas, Edward G. Alveyn, Andrew I. Rutherford, James B. Galloway
Publikováno v:
The Journal of Rheumatology. 49:725-730
Objective.To identify predictors of admission following emergency department (ED) attendances for gout flares and to describe barriers to optimal inpatient gout care.Methods.ED attendances and hospital admissions with primary diagnoses of gout were a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fd671efc49a773a10c0ca061a343d8b
https://doi.org/10.3899/jrheum.211203
https://doi.org/10.3899/jrheum.211203
Autor:
James Galloway, Mark Yates, Benjamin D Clarke, Andrew P. Cope, Mark D Russell, Sam Norton, Andrew I Rutherford, Maryam Adas, Katie Bechman, Victoria B Allen
Publikováno v:
Rheumatology (Oxford, England)
Objectives To evaluate the safety of treatment strategies in patients with early RA. Methods Systematic searches of MEDLINE, EMBASE and PubMed were conducted up to September 2020. Double-blind randomized controlled trials (RCTs) of licensed treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4eb3dc85315700c5e91632032072a7
https://doi.org/10.1093/rheumatology/keab429
https://doi.org/10.1093/rheumatology/keab429
Autor:
Jamie Thoroughgood, Benjamin D Clarke, Rizwan Rajak, Suma Mahendrakar, Vijay Hajela, James Galloway, Grace Baxter, Natalie Horwood, Mark Lloyd, Cristina Tacu, Diane Hill, Patrick Kiely, Ioana A Onac, Thomas Batty, Hannah Irvine, Sian Griffith, Sandra Smith
Publikováno v:
Rheumatology. 60:5233-5238
Objective Real-world secukinumab gastrointestinal-related adverse events (GIRAE) data during treatment for AS and PsA are lacking. We aimed to obtain this through baseline evaluation of pre-existing IBD rates and predictors of GIRAE. Methods Patient
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::831e3afec875b85f6cdcdd5fd3a5f8e1
https://doi.org/10.1093/rheumatology/keab193
https://doi.org/10.1093/rheumatology/keab193
Autor:
Benjamin D Clarke, Sathiyaa Balachandran, Deepak Nagra, Mark D Russell, Katie Bechman, Maryam Adas, Anthony Hope-Smith, Mark Yates, Alastair Barrow, Tom Smith, James Galloway
Publikováno v:
Rheumatology. 61
Background/Aims The impact of dealing with COVID-19 for rheumatology higher specialist trainees has been profound. Sacrifices were made to their training to support the UK's pandemic response. Virtual Reality (VR) has long been used as a solution for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a08a0a8d956081f966fb37a4cfa709a
https://doi.org/10.1093/rheumatology/keac133.087
https://doi.org/10.1093/rheumatology/keac133.087
Autor:
Katie Bechman, Mark Yates, Hannah Wright, Mark Russell, Deepak Nagra, Benjamin D Clarke, Joanna Ledingham, Sam Norton, James Galloway
Publikováno v:
Rheumatology. 61
Background/Aims Online patient-reported outcome measures (PROMs) enable remote collection of perceptions of health status, function and wellbeing. Single-centre studies report that PROM completion is dependent on patient demographics. Here we use a l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1427e41ce761f76b340beea5b8cbf445
https://doi.org/10.1093/rheumatology/keac132.039
https://doi.org/10.1093/rheumatology/keac132.039
Autor:
Sam Norton, James Galloway, Elena Nikiphorou, Mariam Molokhia, Katie Bechman, Andrew I Rutherford, Andrew P. Cope, Kimme L. Hyrich, Benjamin D Clarke, Mark Yates
Publikováno v:
British Society for Rheumatology Biologics Register, Bechman, K, Clarke, B D, Rutherford, A I, Yates, M, Nikiphorou, E, Molokhia, M, Norton, S, Cope, A P, Hyrich, K & Galloway, J B 2019, ' Polypharmacy is associated with treatment response and serious adverse events : results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis ', Rheumatology (Oxford), vol. 58, no. 10, pp. 1767-1776 . https://doi.org/10.1093/rheumatology/kez037
Objective To evaluate whether polypharmacy is associated with treatment response and serious adverse events (SAEs) in patients with RA using data from the British Society for Rheumatology Biologics Register (BSRBR-RA). Methods The BSRBR-RA is a prosp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c67e2e7725632e409fc751308b534e9
https://doi.org/10.1093/rheumatology/kez037
https://doi.org/10.1093/rheumatology/kez037
Publikováno v:
Rheumatology (Oxford, England)
Background/Aims In an era of increasingly stretched health care resources, accompanied by pressures to deliver more care for people with long term conditions remotely, we need innovative solutions to measure disease activity. In the case of monitorin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a00d2943b758f2cc2070c952ed9b0ce6
https://doi.org/10.1093/rheumatology/keab247.134
https://doi.org/10.1093/rheumatology/keab247.134
Autor:
Benjamin D Clarke, Deepak Nagra, Sam Norton, Vishit Patel, Mark Yates, Katie Bechman, Mark D Russell, April Buazon, Jennifer Hannah, Andrew I Rutherford, Maryam Adas, Victoria B Allen, James Galloway, Emmanuel Tharmarajah
Publikováno v:
The Journal of Infection
Summary Objectives Multiple RCTs of interleukin-6 (IL-6) inhibitors in COVID-19 have been published, with conflicting conclusions. We performed a meta-analysis to assess the impact of IL-6 inhibition on mortality from COVID-19, utilising meta-regress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::144ffd3d1aac9581d7190c353e04d6b4
http://europepmc.org/articles/PMC7970418
http://europepmc.org/articles/PMC7970418
Publikováno v:
Rheumatology (Oxford, England)
As efficacy and safety data emerge, differences between JAK inhibitor subclasses are appearing. JAK1 selective drugs, upadacitinib and filgotinib, have broadly come with the same overarching safety recommendations as other immunosuppressive drugs for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c774f3f5ff1af4988ea5727089690c
https://pubmed.ncbi.nlm.nih.gov/33950230
https://pubmed.ncbi.nlm.nih.gov/33950230
Autor:
James Galloway, Carole Reid, Ivana Carey, Sam Norton, Raeesa Jina, Mark D Russell, Fleur Cantle, James T. Teo, Ajay M. Shah, Ruth Sneep, Benjamin D Clarke, Sarah Williams, Leah Sugarman, Mark Yates, Andrew Brookes, Richard D. Barker
Publikováno v:
Journal of Infection
Scientific Reports
Scientific Reports
Background: The COVID-19 pandemic continues to escalate. There is urgent need to stratify patients. Understanding risk of deterioration will assist in admission and discharge decisions, and help selection for clinical studies to indicate where risk o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::060da1bd703da2ad9515ed3896d27761